| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 51.481.689 $ | 99,16 | 485.356 | ||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 5.981.365 $ | 11,52 | 5.413 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 2.722.639 $ | 5,24 | 7.159 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | DK0062498333 | Long | Börsenkurs (Stufe 1) | 2.718.168 $ | 5,24 | 59.455 | |
| Roche Holding AG | Roche Holding AG | EC | 771195104 | Long | Börsenkurs (Stufe 1) | 2.333.791 $ | 4,50 | 44.538 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 2.216.740 $ | 4,27 | 18.672 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 2.077.660 $ | 4,00 | 11.178 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 2.061.154 $ | 3,97 | 4.185 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 1.864.380 $ | 3,59 | 8.274 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.782.676 $ | 3,43 | 13.261 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Börsenkurs (Stufe 1) | 1.755.036 $ | 3,38 | 11.627 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.727.713 $ | 3,33 | 10.971 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 1.520.741 $ | 2,93 | 3.398 | |
| Danaher Corp | Danaher Corp | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 1.380.437 $ | 2,66 | 7.557 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 1.353.250 $ | 2,61 | 15.809 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 1.346.867 $ | 2,59 | 20.327 | |
| Cytokinetics Inc | Cytokinetics Inc | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 1.310.216 $ | 2,52 | 17.069 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 1.244.052 $ | 2,40 | 5.714 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 1.082.932 $ | 2,09 | 18.939 | |
| Teva Pharmaceutical Industries | Teva Pharmaceutical Industries Ltd | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 1.069.242 $ | 2,06 | 30.273 | |
| Dexcom Inc | Dexcom Inc | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 996.375 $ | 1,92 | 13.512 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 992.183 $ | 1,91 | 2.946 | |
| Medtronic PLC | Medtronic PLC | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 974.513 $ | 1,88 | 13.203 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 906.897 $ | 1,75 | 10.488 | |
| McKesson Corp | McKesson Corp | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 887.958 $ | 1,71 | 1.196 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 865.610 $ | 1,67 | 1.408 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 755.353 $ | 1,45 | 1.519 | |
| Boston Scientific Corp | Boston Scientific Corp | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 738.418 $ | 1,42 | 15.285 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Börsenkurs (Stufe 1) | 689.525 $ | 1,33 | 13.915 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 675.178 $ | 1,30 | 1.590 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 590.069 $ | 1,14 | 1.954 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 564.068 $ | 1,09 | 7.240 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 475.597 $ | 0,92 | 9.647 | |
| Xenon Pharmaceuticals Inc | Xenon Pharmaceuticals Inc | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 459.349 $ | 0,88 | 8.393 | |
| Ionis Pharmaceuticals Inc | Ionis Pharmaceuticals Inc | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 428.324 $ | 0,83 | 5.599 | |
| Insulet Corp | Insulet Corp | EC | 45784P101 | Long | Börsenkurs (Stufe 1) | 410.905 $ | 0,79 | 2.835 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 393.313 $ | 0,76 | 1.755 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 368.733 $ | 0,71 | 3.449 | |
| Stoke Therapeutics Inc | Stoke Therapeutics Inc | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 310.615 $ | 0,60 | 10.049 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 279.534 $ | 0,54 | 8.538 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 275.709 $ | 0,53 | 8.761 | |
| Zealand Pharma A/S | Zealand Pharma A/S | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 268.377 $ | 0,52 | 5.293 | |
| Gubra A/S | Gubra A/S | EC | DK0062266474 | Long | Börsenkurs (Stufe 1) | 250.268 $ | 0,48 | 4.487 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 195.460 $ | 0,38 | 13.892 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 180.295 $ | 0,35 | 4.583 | |
| Gesamt | 51.481.689 $ | 99,16 | 485.356 |